💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
|
🏷️ 产品编码
RB9T37015235
|
🧬 中文名称
抗人激活素RIIA/B参考抗体
|
|
📝 英文名称
Anti-Human Activin RIIA/B Reference Antibody
| |
|
📦 形态
Liquid
|
🧪 纯度
>95% purity as determined by SDS-PAGE.
|
|
🔹 内毒素水平
Please contact the lab for this information.
| |
|
🔬 应用
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
| |
|
🧫 表达系统
Mammalian Cells
|
🔢 登录号
P27037 & Q13705
|
|
🔹 宿主种属
Human
|
🔹 克隆性
Monoclonal
|
|
🔹 抗体亚型
IgG1-lambda
|
🔹 纯化方式
Protein A/G purified from cell culture supernatant.
|
|
🔹 浓度
1.99mg/ml
|
🔹 种属反应性
Human
|
|
🔹 靶标
ACVR2, ACTRIIA, ACTR-IIA, Activin receptor type IIA, ACVR2A, Activin receptor type-2A, ACTR-IIB, Activin receptor type IIB, Activin receptor type-2B, ACVR2B
|
🔹 背景信息
Bimagrumab is a monoclonal anti-ActRIIA/IIB antibody that targets ActRIIA and ActRIIB simultaneously. Native ActRIIA and ActRIIB are both mediators of signaling from several TGFβ superfamily members such as activins, myostatin, and GDF11. Hence, pan-blockade by Bimagrumab achieves greater effect than a monoclonal antibody against either receptor alone, i.e. monotherapy with anti-ActRIIA antibody or anti-ActRIIB antibody. Bimagrumab has been explored as a therapy for sporadic inclusion body myositis, primary sarcopenia, and muscle wasting associated with chronic obstructive pulmonary disease.
• Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B., PMID:26047946 • BMPR2 inhibits activin and BMP signaling via wild-type ALK2., PMID:29739878 • ALK2/ALK3-BMPR2/ACVR2A Mediate BMP2-Induced Downregulation of Pentraxin 3 Expression in Human Granulosa-Lutein Cells., PMID:28977600 • Follicular localization of growth differentiation factor 8 and its receptors in normal and polycystic ovary syndrome ovaries., PMID:29409020 |
|
🏷️ 别名
BYM338, 1356922-05-8
| |
🧴 储存缓冲液
0.01M PBS, pH 7.4.
❄️ 稳定性和储存
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
⚠️ For research use only. Not suitable for clinical or therapeutic use.